$11.70
0.817.44%
Last update: Nov 13, 3:31 PM
Cellebrite DI Ltd
CLBTNASDAQ
Cellebrite DI fell 43.5% from $19.28 to $10.89, behind the S&P 500's +12.7%. Its worst day was Aug 13 (−29.2%), and its low came Aug 17 at $10.44.
Nov 13, 2025 – Nov 12, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
EPS of $0.14 beat the $0.13 estimate on $128.8M revenue (est. $126.5M); FY revenue guidance of $565.0M–$571.0M against the $556.0M consensus.
−4.6% · S&P 500 0.0%
Story events cover the past 12 months · Times ET
Cellebrite DI shares fell 11.1%, while the S&P 500 fell 0.1%.
−11.1% · S&P 500 −0.1%
EPS of $0.12 beat the $0.09 estimate on $128.3M revenue (est. $127.1M); FY revenue guidance of $565.0M–$571.0M against the $568.4M consensus.
+8.4% · S&P 500 +0.8%
Cellebrite DI shares rose 11.6%, while the S&P 500 rose 0.2%.
+11.6%, the year's best day · S&P 500 +0.2%
EPS of $0.11 beat the $0.11 estimate on $131.1M revenue (est. $132.1M); FY revenue guidance of $555.0M–$561.0M against the $568.1M consensus.
−29.2%, the year's worst day, on 37M shares, the year's heaviest volume · S&P 500 +0.7%
EPS of $0.17 beat the $0.15 estimate on $149.0M revenue (est. $145.8M); FY revenue guidance of $553.0M–$558.0M against the $556.8M consensus.
−14.3% · S&P 500 −0.4%
Where it ended: a close of $10.89 on Nov 12, 2026. Up next: Q4 2026 earnings on Feb 10, 2027 (EPS est. $0.17, revenue est. $151.6M).
Nothing in the past 12 months.
All CLBT dividend historyReplay the year: the line draws itself and stops at each of the 6 moments with what happened and how the stock reacted.
Chart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for CLBT and SPY from Benzinga historical bars. Not investment advice.
